Although FXR, HIF2a, and MYC alter ceramide formation through unique processes, each system promotes the delivery of ceramides from the intestine to other tissues, including the liver, thereby impairing systemic metabolic integrity in obesity. This evidence concerns the gene MYC and Obesity.